1
|
Martin JT, Boynton GM, Baker DH, Wade AR, Spitschan M. PySilSub: An open-source Python toolbox for implementing the method of silent substitution in vision and nonvisual photoreception research. J Vis 2023; 23:10. [PMID: 37450287 PMCID: PMC10353748 DOI: 10.1167/jov.23.7.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2023] [Accepted: 06/11/2023] [Indexed: 07/18/2023] Open
Abstract
The normal human retina contains several classes of photosensitive cell-rods for low-light vision, three cone classes for daylight vision, and intrinsically photosensitive retinal ganglion cells (ipRGCs) expressing melanopsin for non-image-forming functions, including pupil control, melatonin suppression, and circadian photoentrainment. The spectral sensitivities of the photoreceptors overlap significantly, which means that most lights will stimulate all photoreceptors to varying degrees. The method of silent substitution is a powerful tool for stimulating individual photoreceptor classes selectively and has found much use in research and clinical settings. The main hardware requirement for silent substitution is a spectrally calibrated light stimulation system with at least as many primaries as there are photoreceptors under consideration. Device settings that will produce lights to selectively stimulate the photoreceptor(s) of interest can be found using a variety of analytic and algorithmic approaches. Here we present PySilSub (https://github.com/PySilentSubstitution/pysilsub), a novel Python package for silent substitution featuring flexible support for individual colorimetric observer models (including human and mouse observers), multiprimary stimulation devices, and solving silent substitution problems with linear algebra and constrained numerical optimization. The toolbox is registered with the Python Package Index and includes example data sets from various multiprimary systems. We hope that PySilSub will facilitate the application of silent substitution in research and clinical settings.
Collapse
Affiliation(s)
- Joel T Martin
- Department of Psychology, University of York, York, UK
| | | | - Daniel H Baker
- Department of Psychology, University of York, York, UK
- York Biomedical Research Institute, University of York, York, UK
| | - Alex R Wade
- Department of Psychology, University of York, York, UK
- York Biomedical Research Institute, University of York, York, UK
| | - Manuel Spitschan
- Max Planck Institute for Biological Cybernetics, Tübingen, Germany
- TUM Department of Sport and Health Sciences (TUM SG), Technical University of Munich, Munich, Germany
- TUM Institute for Advanced Study (TUM-IAS), Technical University of Munich, Garching, Germany
| |
Collapse
|
2
|
Neumann A, Breher K, Wahl S. Effects of screen-based retinal light stimulation measured with a novel contrast sensitivity test. PLoS One 2021; 16:e0254877. [PMID: 34324537 PMCID: PMC8320929 DOI: 10.1371/journal.pone.0254877] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Accepted: 07/05/2021] [Indexed: 02/02/2023] Open
Abstract
Myopia is increasing worldwide hence it exists a pressing demand to find effective myopia control strategies. Previous studies have shown that light, spectral composition, spatial frequencies, and contrasts play a critical role in refractive development. The effects of light on multiple retinal processes include growth regulation, but also visual performance and perception. Changes in subjective visual performance can be examined by contrast sensitivity (CS). This study was conducted to investigate whether retinal light stimulation of different wavelength ranges is able to elicit changes in CS and, therefore, may be used for myopia control purposes. In total, 30 right eyes were stimulated with the light of different wavelength ranges, including dominant wavelengths of ∼480 nm, ∼530 nm, ∼630 nm and polychromatic light via a commercial liquid crystal display (LCD) screen. Stimulation was performed screen full-field and on the optic nerve head only. CS was measured before any stimulation and after each stimulation condition using a novel and time-efficient CS test. Post-stimulation CS changes were analyzed by ANOVA regarding the influencing factors spatial frequency, stimulation wavelength and stimulation location. A priorly conducted verification study on a subset of five participants compared the newly developed CS test to a validated CS test. The novel CS test exhibited good reliability of 0.94 logCS and repeatability of 0.13 logCS with a duration of 92 sec ± 17 sec. No clinically critical change between pre- and post-stimulation CS was detected (all p>0.05). However, the results showed that post-stimulation CS differed significantly at 18 cpd after stimulation with polychromatic light from short-wavelength light (p<0.0001). Location of illumination (screen full-field vs. optic nerve head) or any interactions with other factors did not reveal significant influences (all p>0.05). To summarize, a novel CS test measures the relationship between retinal light stimulation and CS. However, using retinal illumination via LCD screens to increase CS is inconclusive.
Collapse
Affiliation(s)
- Antonia Neumann
- Institute for Ophthalmic Research, Eberhard Karls University Tübingen, Tübingen, Germany
| | - Katharina Breher
- Institute for Ophthalmic Research, Eberhard Karls University Tübingen, Tübingen, Germany
- Carl Zeiss Vision International GmbH, Aalen, Germany
| | - Siegfried Wahl
- Institute for Ophthalmic Research, Eberhard Karls University Tübingen, Tübingen, Germany
- Carl Zeiss Vision International GmbH, Aalen, Germany
| |
Collapse
|
3
|
McAdams H, Kaiser EA, Igdalova A, Haggerty EB, Cucchiara B, Brainard DH, Aguirre GK. Selective amplification of ipRGC signals accounts for interictal photophobia in migraine. Proc Natl Acad Sci U S A 2020; 117:17320-17329. [PMID: 32632006 PMCID: PMC7382295 DOI: 10.1073/pnas.2007402117] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Second only to headache, photophobia is the most debilitating symptom reported by people with migraine. While the melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) are thought to play a role, how cone and melanopsin signals are integrated in this pathway to produce visual discomfort is poorly understood. We studied 60 people: 20 without headache and 20 each with interictal photophobia from migraine with or without visual aura. Participants viewed pulses of spectral change that selectively targeted melanopsin, the cones, or both and rated the degree of visual discomfort produced by these stimuli while we recorded pupil responses. We examined the data within a model that describes how cone and melanopsin signals are weighted and combined at the level of the retina and how this combined signal is transformed into a rating of discomfort or pupil response. Our results indicate that people with migraine do not differ from headache-free controls in the manner in which melanopsin and cone signals are combined. Instead, people with migraine demonstrate an enhanced response to integrated ipRGC signals for discomfort. This effect of migraine is selective for ratings of visual discomfort, in that an enhancement of pupil responses was not seen in the migraine group, nor were group differences found in surveys of other behaviors putatively linked to ipRGC function (chronotype, seasonal sensitivity, presence of a photic sneeze reflex). By revealing a dissociation in the amplification of discomfort vs. pupil response, our findings suggest a postretinal alteration in processing of ipRGC signals for photophobia in migraine.
Collapse
Affiliation(s)
- Harrison McAdams
- Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Eric A Kaiser
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Aleksandra Igdalova
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Edda B Haggerty
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - Brett Cucchiara
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
| | - David H Brainard
- Department of Psychology, University of Pennsylvania, Philadelphia, PA 19104
| | - Geoffrey K Aguirre
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
| |
Collapse
|
4
|
de Zeeuw J, Papakonstantinou A, Nowozin C, Stotz S, Zaleska M, Hädel S, Bes F, Münch M, Kunz D. Living in Biological Darkness: Objective Sleepiness and the Pupillary Light Responses Are Affected by Different Metameric Lighting Conditions during Daytime. J Biol Rhythms 2019; 34:410-431. [PMID: 31156018 PMCID: PMC6637815 DOI: 10.1177/0748730419847845] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Nighttime melatonin suppression is the most commonly used method to indirectly quantify acute nonvisual light effects. Since light is the principal zeitgeber in humans, there is a need to assess its strength during daytime as well. This is especially important since humans evolved under natural daylight but now often spend their time indoors under artificial light, resulting in a different quality and quantity of light. We tested whether the pupillary light response (PLR) could be used as a marker for nonvisual light effects during daytime. We also recorded the wake electroencephalogram to objectively determine changes in daytime sleepiness between different illuminance levels and/or spectral compositions of light. In total, 72 participants visited the laboratory 4 times for 3-h light exposures. All participants underwent a dim-light condition and either 3 metameric daytime light exposures with different spectral compositions of polychromatic white light (100 photopic lux, peak wavelengths at 435 nm or 480 nm, enriched with longer wavelengths of light) or 3 different illuminances (200, 600, and 1200 photopic lux) with 1 metameric lighting condition (peak wavelength at 435 nm or 480 nm; 24 participants each). The results show that the PLR was sensitive to both spectral differences between metameric lighting conditions and different illuminances in a dose-responsive manner, depending on melanopic irradiance. Objective sleepiness was significantly reduced, depending on melanopic irradiance, at low illuminance (100 lux) and showed fewer differences at higher illuminance. Since many people are exposed to such low illuminance for most of their day—living in biological darkness—our results imply that optimizing the light spectrum could be important to improve daytime alertness. Our results suggest the PLR as a noninvasive physiological marker for ambient light exposure effects during daytime. These findings may be applied to assess light-dependent zeitgeber strength and evaluate lighting improvements at workplaces, schools, hospitals, and homes.
Collapse
Affiliation(s)
- Jan de Zeeuw
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,Intellux GmbH, Berlin, Germany
| | - Alexandra Papakonstantinou
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin
| | - Claudia Nowozin
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin
| | - Sophia Stotz
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin
| | | | - Sven Hädel
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology
| | - Frederik Bes
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin
| | - Mirjam Münch
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin.,Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Medical Immunology, Laboratory of Chronobiology.,Sleep/Wake Research Centre, Massey University, Wellington, New Zealand
| | - Dieter Kunz
- Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Sleep Research & Clinical Chronobiology.,Intellux GmbH, Berlin, Germany.,St. Hedwig-Hospital, Clinic for Sleep & Chronomedicine, Berlin
| |
Collapse
|